GURU
发表于 2025-3-21 17:17:08
书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221704<br><br> <br><br>书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221704<br><br> <br><br>
canvass
发表于 2025-3-21 21:16:36
http://reply.papertrans.cn/23/2218/221704/221704_2.png
GOAT
发表于 2025-3-22 02:36:48
Imaging of Renal Parenchymal Tumorsons. Therefore, optimization of the imaging techniques is a continuous challenge for radiologists. Once a renal mass is detected, the radiologist is faced with two additional tasks: (1) to determine whether it is a simple renal cyst/benign lesion or a malignant tumor, or more simply, whether or not
FLINT
发表于 2025-3-22 05:58:26
http://reply.papertrans.cn/23/2218/221704/221704_4.png
CLOT
发表于 2025-3-22 10:14:59
Nephron-Sparing Surgerycancer, the mortality from kidney cancer can be estimated to be twice as high as that from bladder and 3 times as high as that from prostate cancer. The clinical picture of renal cell carcinoma has, however, changed completely during the last decade. Most tumors are no longer presenting at a locally
注意到
发表于 2025-3-22 14:00:46
Palliative Surgical Therapyetastatic disease at presentation. Following nephrectomy for apparently localized disease, 50% of patients will develop progression with the occurrence of distant metastases or locoregional recurrence. Most of these patients die within 1 year and the reported 5-year survival rates vary between 0% an
注意到
发表于 2025-3-22 19:47:10
http://reply.papertrans.cn/23/2218/221704/221704_7.png
先兆
发表于 2025-3-23 00:49:21
Immunotherapy and Chemotherapy for Metastatic Renal Cell Carcinomanosis (. et al. 1997). For these patients the prognosis is poor, with an estimated median survival of less than 1 year and an overall 5-year survival of less than 20% (. et al. 1991). Spontaneous remissions of metastatic lesions have on rare occasions been documented to occur after removal of the pr
镇痛剂
发表于 2025-3-23 01:54:56
The Role of Radiotherapy in the Management of Patients with Renal Cell Carcinomaf all genitourinary tumors in incidence and 18% in mortality rates (. et al. 1998). Most (>80%) tumors of the kidneys are renal cell carcinomas (RCCs), which show a predilection to occur in males in their fifth and sixth decades of life, although this tumor is known to occur in much younger patients
钻孔
发表于 2025-3-23 06:51:36
http://reply.papertrans.cn/23/2218/221704/221704_10.png